BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9562602)

  • 1. Combinatorial chemistry techniques applied to nonpeptide integrin antagonists.
    Hoekstra WJ; Poulter BL
    Curr Med Chem; 1998 Jun; 5(3):195-204. PubMed ID: 9562602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents.
    Scarborough RM; Gretler DD
    J Med Chem; 2000 Sep; 43(19):3453-73. PubMed ID: 10999999
    [No Abstract]   [Full Text] [Related]  

  • 3. The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic.
    Fotouhi N; Joshi P; Fry D; Cook C; Tilley JW; Kaplan G; Hanglow A; Rowan K; Schwinge V; Wolitzky B
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1171-3. PubMed ID: 10866374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
    Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and SAR of N-substituted dibenzazepinone derivatives as novel potent and selective alpha(V)beta(3) antagonists.
    Kling A; Backfisch G; Delzer J; Geneste H; Graef C; Holzenkamp U; Hornberger W; Lange UE; Lauterbach A; Mack H; Seitz W; Subkowski T
    Bioorg Med Chem Lett; 2002 Feb; 12(3):441-6. PubMed ID: 11814816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-phase synthesis of a nonpeptide RGD mimetic library: new selective alphavbeta3 integrin antagonists.
    Sulyok GA; Gibson C; Goodman SL; Hölzemann G; Wiesner M; Kessler H
    J Med Chem; 2001 Jun; 44(12):1938-50. PubMed ID: 11384239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.
    Lin Kc; Ateeq HS; Hsiung SH; Chong LT; Zimmerman CN; Castro A; Lee WC; Hammond CE; Kalkunte S; Chen LL; Pepinsky RB; Leone DR; Sprague AG; Abraham WM; Gill A; Lobb RR; Adams SP
    J Med Chem; 1999 Mar; 42(5):920-34. PubMed ID: 10072689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbacyclic peptide mimetics as VCAM-VLA-4 antagonists.
    Tilley J; Kaplan G; Fotouhi N; Wolitzky B; Rowan K
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1163-5. PubMed ID: 10866372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists.
    Fotouhi N; Joshi P; Tilley JW; Rowan K; Schwinge V; Wolitzky B
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1167-9. PubMed ID: 10866373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
    Lin KC; Castro AC
    Curr Opin Chem Biol; 1998 Aug; 2(4):453-7. PubMed ID: 9736917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and evaluation of potent, cysteine-based alpha4beta1 integrin antagonists.
    Archibald SC; Head JC; Linsley JM; Porter JR; Robinson MK; Shock A; Warrellow GJ
    Bioorg Med Chem Lett; 2000 May; 10(9):993-5. PubMed ID: 10853676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the research of GPIIb/IIIa antagonists.
    Xie Z; Cao C; Feng S; Huang J; Li Z
    Future Med Chem; 2015; 7(9):1149-71. PubMed ID: 26132524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potent and novel alpha4beta1 antagonists using in silico screening.
    Singh J; Van Vlijmen H; Liao Y; Lee WC; Cornebise M; Harris M; Shu IH; Gill A; Cuervo JH; Abraham WM; Adams SP
    J Med Chem; 2002 Jul; 45(14):2988-93. PubMed ID: 12086484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross talk between alpha(v)beta3 and alpha4beta1 integrins regulates lymphocyte migration on vascular cell adhesion molecule 1.
    Imhof BA; Weerasinghe D; Brown EJ; Lindberg FP; Hammel P; Piali L; Dessing M; Gisler R
    Eur J Immunol; 1997 Dec; 27(12):3242-52. PubMed ID: 9464812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
    Lark MW; Stroup GB; Hwang SM; James IE; Rieman DJ; Drake FH; Bradbeer JN; Mathur A; Erhard KF; Newlander KA; Ross ST; Salyers KL; Smith BR; Miller WH; Huffman WF; Gowen M
    J Pharmacol Exp Ther; 1999 Nov; 291(2):612-7. PubMed ID: 10525079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
    Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
    Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents.
    Jackson DY; Quan C; Artis DR; Rawson T; Blackburn B; Struble M; Fitzgerald G; Chan K; Mullins S; Burnier JP; Fairbrother WJ; Clark K; Berisini M; Chui H; Renz M; Jones S; Fong S
    J Med Chem; 1997 Oct; 40(21):3359-68. PubMed ID: 9341911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of integrin antagonists containing trans- and cis-2,5-disubstituted THF rings.
    Osterkamp F; Ziemer B; Koert U; Wiesner M; Raddatz P; Goodman SL
    Chemistry; 2000 Feb; 6(4):666-83. PubMed ID: 10807178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of sulfonylated dipeptides as potent VLA-4 antagonists.
    Hagmann WK; Durette PL; Lanza T; Kevin NJ; de Laszlo SE; Kopka IE; Young D; Magriotis PA; Li B; Lin LS; Yang G; Kamenecka T; Chang LL; Wilson J; MacCoss M; Mills SG; Van Riper G; McCauley E; Egger LA; Kidambi U; Lyons K; Vincent S; Stearns R; Colletti A; Teffera J; Tong S; Fenyk-Melody J; Owens K; Levorse D; Kim P; Schmidt JA; Mumford RA
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2709-13. PubMed ID: 11591507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.